MeVC21 (R), n=3 cell(s)

Main group: Visual Centrifugal Neurons; Neurotransmitter consensus prediction: Glu

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - 5.3 3.3 5.0 14.7 357.0 151.0 24.7 - 561.0
1 - - 0.3 0.7 0.7 10.3 327.3 150.7 15.3 0.3 505.7
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - 1.0 23.3 86.3 536.3 647.0
Pre - - - - 0.3 3.7 47.3 51.3
  AME
0 79.7
1 4.7
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 83.3
1 6.0

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:1683
Number of pre synapses:1517
Number of output connections:3064
Coverage factor:1.5
Columnar completeness:0.74
Area completeness:0.95
Cell size (columns):318

Lobula

Number of post synapses:1941
Number of pre synapses:154
Number of output connections:284
Coverage factor:1.5
Columnar completeness:0.49
Area completeness:0.77
Cell size (columns):213

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVC21 (R) % % cumu.
0 MeLo1 (R) ACh 613 204.3 13.3% 13.3%
1 Tm20 (R) ACh 442 147.3 9.6% 22.9%
2 MeVP14 (R) ACh 347 115.7 7.5% 30.4%
3 MeVPLo2 (L) ACh 212 70.7 4.6% 35.0%
4 MeVP1 (R) ACh 207 69.0 4.5% 39.5%
5 DN1a (R) unclear 193 64.3 4.2% 43.7%
6 MeVPLo2 (R) ACh 188 62.7 4.1% 47.8%
7 Li23 (R) ACh 178 59.3 3.9% 51.6%
8 TmY10 (R) ACh 149 49.7 3.2% 54.9%
9 MeLo6 (R) ACh 137 45.7 3.0% 57.8%
10 MeVC27 (L) unclear 121 40.3 2.6% 60.5%
11 Tm34 (R) Glu 110 36.7 2.4% 62.8%
12 Li14 (R) Glu 92 30.7 2.0% 64.8%
13 Tm5a (R) ACh 85 28.3 1.8% 66.7%
14 Mi10 (R) ACh 75 25.0 1.6% 68.3%
15 Tm30 (R) GABA 64 21.3 1.4% 69.7%
16 LoVP96 (R) Glu 62 20.7 1.3% 71.0%
17 MeLo2 (R) ACh 56 18.7 1.2% 72.3%
18 LC14b (L) ACh 39 13.0 0.8% 73.1%
19 Cm19 (R) GABA 38 12.7 0.8% 73.9%
20 LT43 (R) GABA 37 12.3 0.8% 74.7%
21 MeLo3b (R) ACh 35 11.7 0.8% 75.5%
22 Cm31b (R) GABA 34 11.3 0.7% 76.2%
23 aMe12 (R) ACh 27 9.0 0.6% 76.8%
24 LPT51 (R) Glu 26 8.7 0.6% 77.4%
25 MeVC24 (R) Glu 26 8.7 0.6% 77.9%
26 MeVC23 (R) Glu 25 8.3 0.5% 78.5%
27 Cm8 (R) GABA 24 8.0 0.5% 79.0%
28 LC37 (R) Glu 23 7.7 0.5% 79.5%
29 Cm10 (R) GABA 21 7.0 0.5% 80.0%
30 MeVPMe11 (L) Glu 21 7.0 0.5% 80.4%
31 Tm37 (R) Glu 21 7.0 0.5% 80.9%
32 Li20 (R) Glu 19 6.3 0.4% 81.3%
33 MeVPaMe1 (R) ACh 19 6.3 0.4% 81.7%
34 MeVPaMe2 (L) Glu 19 6.3 0.4% 82.1%
35 Li39 (L) GABA 18 6.0 0.4% 82.5%
36 MeVPaMe1 (L) ACh 18 6.0 0.4% 82.9%
37 Mi17 (R) GABA 17 5.7 0.4% 83.3%
38 Tm31 (R) Glu 15 5.0 0.3% 83.6%
39 TmY5a (R) Glu 15 5.0 0.3% 83.9%
40 aMe12 (L) ACh 14 4.7 0.3% 84.2%
41 Cm13 (R) Glu 14 4.7 0.3% 84.5%
42 LoVP6 (R) ACh 14 4.7 0.3% 84.8%
43 MeVC22 (R) Glu 14 4.7 0.3% 85.1%
44 MeVP15 (R) ACh 14 4.7 0.3% 85.4%
45 Li33 (R) ACh 13 4.3 0.3% 85.7%
46 aMe6a (R) ACh 12 4.0 0.3% 86.0%
47 Cm17 (R) GABA 12 4.0 0.3% 86.2%
48 LT88 (R) Glu 12 4.0 0.3% 86.5%
49 MeVP11 (R) ACh 12 4.0 0.3% 86.7%
50 MeVP29 (R) ACh 12 4.0 0.3% 87.0%
51 Tm38 (R) ACh 12 4.0 0.3% 87.3%
52 Li21 (R) ACh 11 3.7 0.2% 87.5%
53 MeVC20 (R) Glu 11 3.7 0.2% 87.7%
54 aMe8 (R) ACh 10 3.3 0.2% 88.0%
55 LC39a (R) Glu 10 3.3 0.2% 88.2%
56 Cm34 (R) Glu 9 3.0 0.2% 88.4%
57 Cm4 (R) Glu 9 3.0 0.2% 88.6%
58 Dm2 (R) ACh 9 3.0 0.2% 88.8%
59 MeVPLo1 (R) Glu 9 3.0 0.2% 89.0%
60 Pm8 (R) GABA 9 3.0 0.2% 89.2%
61 TmY17 (R) ACh 9 3.0 0.2% 89.3%
62 TmY21 (R) ACh 9 3.0 0.2% 89.5%
63 Cm31a (R) GABA 8 2.7 0.2% 89.7%
64 DNpe053 (L) ACh 8 2.7 0.2% 89.9%
65 LC14a-1 (L) ACh 8 2.7 0.2% 90.1%
66 LoVCLo1 (R) ACh 8 2.7 0.2% 90.2%
67 Tm35 (R) Glu 8 2.7 0.2% 90.4%
68 Tm5Y (R) ACh 8 2.7 0.2% 90.6%
69 aMe6b (R) ACh 7 2.3 0.2% 90.7%
70 Cm7 (R) Glu 7 2.3 0.2% 90.9%
71 LC10b (R) ACh 7 2.3 0.2% 91.0%
72 LC13 (R) ACh 7 2.3 0.2% 91.2%
73 LC20a (R) ACh 7 2.3 0.2% 91.3%
74 MeTu4a (R) ACh 7 2.3 0.2% 91.5%
75 Tm33 (R) ACh 7 2.3 0.2% 91.6%
76 Y3 (R) ACh 7 2.3 0.2% 91.8%
77 HBeyelet (R) His 6 2.0 0.1% 91.9%
78 LoVC23 (L) GABA 6 2.0 0.1% 92.1%
79 Cm6 (R) GABA 5 1.7 0.1% 92.2%
80 Dm13 (R) GABA 5 1.7 0.1% 92.3%
81 Dm9 (R) Glu 5 1.7 0.1% 92.4%
82 DNpe053 (R) ACh 5 1.7 0.1% 92.5%
83 LC10e (R) ACh 5 1.7 0.1% 92.6%
84 MeVC4b (L) ACh 5 1.7 0.1% 92.7%
85 MeVP3 (R) ACh 5 1.7 0.1% 92.8%
86 OLVC4 (L) unclear 5 1.7 0.1% 92.9%
87 Pm4 (R) GABA 5 1.7 0.1% 93.0%
88 Tm5c (R) Glu 5 1.7 0.1% 93.1%
89 Y13 (R) Glu 5 1.7 0.1% 93.3%
90 aMe4 (R) ACh 4 1.3 0.1% 93.3%
91 aMe5 (R) ACh 4 1.3 0.1% 93.4%
92 aMe9 (L) ACh 4 1.3 0.1% 93.5%
93 Cm16 (R) Glu 4 1.3 0.1% 93.6%
94 Li34a (R) GABA 4 1.3 0.1% 93.7%
95 LLPC3 (R) ACh 4 1.3 0.1% 93.8%
96 LoVC18 (R) Dop 4 1.3 0.1% 93.9%
97 LoVP62 (R) ACh 4 1.3 0.1% 93.9%
98 LT41 (R) GABA 4 1.3 0.1% 94.0%
99 LT63 (R) ACh 4 1.3 0.1% 94.1%
100 LT64 (R) ACh 4 1.3 0.1% 94.2%
101 LT68 (R) Glu 4 1.3 0.1% 94.3%
102 MeLo3a (R) ACh 4 1.3 0.1% 94.4%
103 MeVPMe4 (L) Glu 4 1.3 0.1% 94.5%
104 Tm32 (R) Glu 4 1.3 0.1% 94.6%
105 Tm_unclear (R) GABA 4 1.3 0.1% 94.6%
106 5-HTPMPV01 (L) unclear 3 1.0 0.1% 94.7%
107 5-HTPMPV03 (L) 5HT 3 1.0 0.1% 94.8%
108 5thsLNv_LNd6 (R) ACh 3 1.0 0.1% 94.8%
109 Cm29 (R) GABA 3 1.0 0.1% 94.9%
110 Cm3 (R) GABA 3 1.0 0.1% 95.0%
111 LC10d (R) ACh 3 1.0 0.1% 95.0%
112 LC27 (R) ACh 3 1.0 0.1% 95.1%
113 LC9 (R) ACh 3 1.0 0.1% 95.2%
114 LoVC22 (L) Dop 3 1.0 0.1% 95.2%
115 LoVC4 (R) GABA 3 1.0 0.1% 95.3%
116 LoVP45 (R) Glu 3 1.0 0.1% 95.4%
117 MeLo13 (R) Glu 3 1.0 0.1% 95.4%
118 MeLo5 (R) ACh 3 1.0 0.1% 95.5%
119 MeLo7 (R) ACh 3 1.0 0.1% 95.6%
120 MeLo8 (R) GABA 3 1.0 0.1% 95.6%
121 MeTu4f (R) ACh 3 1.0 0.1% 95.7%
122 MeVC21 (R) Glu 3 1.0 0.1% 95.7%
123 MeVP6 (R) Glu 3 1.0 0.1% 95.8%
124 MeVP62 (R) ACh 3 1.0 0.1% 95.9%
125 Pm12 (R) Glu 3 1.0 0.1% 95.9%
126 Pm9 (R) GABA 3 1.0 0.1% 96.0%
127 Tm16 (R) ACh 3 1.0 0.1% 96.1%
128 Tm36 (R) ACh 3 1.0 0.1% 96.1%
129 Tm39 (R) ACh 3 1.0 0.1% 96.2%
130 TmY9b (R) ACh 3 1.0 0.1% 96.3%

Outputs

  instance NT total connections connections /#MeVC21 (R) % % cumu.
0 Tm20 (R) ACh 662 220.7 18.3% 18.3%
1 Tm33 (R) ACh 257 85.7 7.1% 25.4%
2 MeLo1 (R) ACh 226 75.3 6.3% 31.7%
3 MeTu2b (R) unclear 183 61.0 5.1% 36.8%
4 TmY10 (R) ACh 138 46.0 3.8% 40.6%
5 TmY21 (R) ACh 95 31.7 2.6% 43.2%
6 Tm5Y (R) ACh 87 29.0 2.4% 45.6%
7 Tm32 (R) Glu 86 28.7 2.4% 48.0%
8 Cm19 (R) GABA 77 25.7 2.1% 50.1%
9 MeVPLo1 (R) Glu 66 22.0 1.8% 52.0%
10 MeVP1 (R) ACh 57 19.0 1.6% 53.5%
11 Cm3 (R) GABA 56 18.7 1.6% 55.1%
12 Tm5a (R) ACh 54 18.0 1.5% 56.6%
13 MeVP6 (R) Glu 38 12.7 1.1% 57.6%
14 Cm29 (R) GABA 36 12.0 1.0% 58.6%
15 Cm17 (R) GABA 34 11.3 0.9% 59.6%
16 Tm31 (R) Glu 34 11.3 0.9% 60.5%
17 Cm5 (R) GABA 30 10.0 0.8% 61.4%
18 Cm8 (R) GABA 30 10.0 0.8% 62.2%
19 TmY17 (R) ACh 30 10.0 0.8% 63.0%
20 Pm4 (R) GABA 29 9.7 0.8% 63.8%
21 Cm13 (R) Glu 28 9.3 0.8% 64.6%
22 MeLo6 (R) ACh 26 8.7 0.7% 65.3%
23 Y3 (R) ACh 26 8.7 0.7% 66.0%
24 Mi10 (R) ACh 25 8.3 0.7% 66.7%
25 Tm34 (R) Glu 25 8.3 0.7% 67.4%
26 Cm7 (R) Glu 24 8.0 0.7% 68.1%
27 Li20 (R) Glu 23 7.7 0.6% 68.7%
28 MeVP14 (R) ACh 21 7.0 0.6% 69.3%
29 T2a (R) ACh 21 7.0 0.6% 69.9%
30 MeLo3b (R) ACh 20 6.7 0.6% 70.4%
31 MeVP50 (R) unclear 20 6.7 0.6% 71.0%
32 Tm37 (R) Glu 20 6.7 0.6% 71.5%
33 TmY5a (R) Glu 20 6.7 0.6% 72.1%
34 MeVP11 (R) ACh 19 6.3 0.5% 72.6%
35 MeLo2 (R) ACh 17 5.7 0.5% 73.1%
36 MeVP3 (R) ACh 17 5.7 0.5% 73.6%
37 Cm34 (R) Glu 16 5.3 0.4% 74.0%
38 Mi17 (R) GABA 16 5.3 0.4% 74.4%
39 MeLo7 (R) ACh 15 5.0 0.4% 74.9%
40 MeVPLo2 (L) ACh 15 5.0 0.4% 75.3%
41 Tm5c (R) Glu 15 5.0 0.4% 75.7%
42 LT88 (R) Glu 14 4.7 0.4% 76.1%
43 MeVP15 (R) ACh 14 4.7 0.4% 76.5%
44 Tm16 (R) ACh 14 4.7 0.4% 76.9%
45 Tm38 (R) ACh 13 4.3 0.4% 77.2%
46 MeVC4a (L) ACh 12 4.0 0.3% 77.5%
47 Tm29 (R) Glu 12 4.0 0.3% 77.9%
48 Tm35 (R) Glu 12 4.0 0.3% 78.2%
49 Cm31b (R) GABA 11 3.7 0.3% 78.5%
50 Li39 (L) GABA 11 3.7 0.3% 78.8%
51 ME_unclear (R) ACh 11 3.7 0.3% 79.1%
52 Mi16 (R) GABA 11 3.7 0.3% 79.4%
53 OLVC5 (R) ACh 11 3.7 0.3% 79.7%
54 Pm12 (R) Glu 11 3.7 0.3% 80.0%
55 TmY14 (R) Glu 11 3.7 0.3% 80.3%
56 aMe8 (R) ACh 10 3.3 0.3% 80.6%
57 Cm10 (R) GABA 10 3.3 0.3% 80.9%
58 Cm21 (R) GABA 10 3.3 0.3% 81.2%
59 Li14 (R) Glu 10 3.3 0.3% 81.5%
60 MeVC23 (R) Glu 10 3.3 0.3% 81.7%
61 TmY4 (R) ACh 10 3.3 0.3% 82.0%
62 Li23 (R) ACh 9 3.0 0.2% 82.3%
63 MeTu4f (R) ACh 9 3.0 0.2% 82.5%
64 Tm5b (R) ACh 9 3.0 0.2% 82.8%
65 Cm20 (R) GABA 8 2.7 0.2% 83.0%
66 MeLo9 (R) Glu 8 2.7 0.2% 83.2%
67 MeVC20 (R) Glu 8 2.7 0.2% 83.4%
68 MeVC27 (L) unclear 8 2.7 0.2% 83.6%
69 MeVP62 (R) ACh 8 2.7 0.2% 83.9%
70 Cm16 (R) Glu 7 2.3 0.2% 84.1%
71 Cm6 (R) GABA 7 2.3 0.2% 84.2%
72 DNpe053 (L) ACh 7 2.3 0.2% 84.4%
73 Lawf2 (R) ACh 7 2.3 0.2% 84.6%
74 MeLo3a (R) ACh 7 2.3 0.2% 84.8%
75 MeTu4c (R) ACh 7 2.3 0.2% 85.0%
76 MeVC22 (R) Glu 7 2.3 0.2% 85.2%
77 MeVC24 (R) Glu 7 2.3 0.2% 85.4%
78 MeVP17 (R) Glu 7 2.3 0.2% 85.6%
79 MeVPaMe1 (L) ACh 7 2.3 0.2% 85.8%
80 Mi18 (R) GABA 7 2.3 0.2% 86.0%
81 Pm2a (R) GABA 7 2.3 0.2% 86.2%
82 Tm12 (R) ACh 7 2.3 0.2% 86.4%
83 Tm26 (R) ACh 7 2.3 0.2% 86.6%
84 Tm40 (R) ACh 7 2.3 0.2% 86.8%
85 Y13 (R) Glu 7 2.3 0.2% 87.0%
86 Dm-DRA1 (R) Glu 6 2.0 0.2% 87.1%
87 LC10c-1 (R) ACh 6 2.0 0.2% 87.3%
88 MeVP18 (R) unclear 6 2.0 0.2% 87.5%
89 MeVPLo2 (R) ACh 6 2.0 0.2% 87.6%
90 Pm8 (R) GABA 6 2.0 0.2% 87.8%
91 Pm9 (R) GABA 6 2.0 0.2% 88.0%
92 SLP250 (R) unclear 6 2.0 0.2% 88.1%
93 T2 (R) ACh 6 2.0 0.2% 88.3%
94 Tm30 (R) GABA 6 2.0 0.2% 88.5%
95 Tm36 (R) ACh 6 2.0 0.2% 88.6%
96 Tm39 (R) ACh 6 2.0 0.2% 88.8%
97 aMe17e (R) Glu 5 1.7 0.1% 88.9%
98 aMe2 (R) Glu 5 1.7 0.1% 89.1%
99 Cm18 (R) Glu 5 1.7 0.1% 89.2%
100 Cm24 (R) Glu 5 1.7 0.1% 89.3%
101 Cm4 (R) Glu 5 1.7 0.1% 89.5%
102 LoVC23 (L) GABA 5 1.7 0.1% 89.6%
103 MeTu2a (R) ACh 5 1.7 0.1% 89.8%
104 MeVP61 (R) unclear 5 1.7 0.1% 89.9%
105 MeVP6_unclear (R) Glu 5 1.7 0.1% 90.0%
106 Mi2 (R) Glu 5 1.7 0.1% 90.2%
107 Tm6 (R) ACh 5 1.7 0.1% 90.3%
108 TmY18 (R) ACh 5 1.7 0.1% 90.4%
109 Y14 (R) Glu 5 1.7 0.1% 90.6%
110 Cm11a (R) ACh 4 1.3 0.1% 90.7%
111 LC10b (R) ACh 4 1.3 0.1% 90.8%
112 Li21 (R) ACh 4 1.3 0.1% 90.9%
113 LPT54 (R) ACh 4 1.3 0.1% 91.0%
114 MeLo11 (R) Glu 4 1.3 0.1% 91.1%
115 MeLo5 (R) ACh 4 1.3 0.1% 91.3%
116 MeTu4a (R) ACh 4 1.3 0.1% 91.4%
117 MeVPMe1 (R) Glu 4 1.3 0.1% 91.5%
118 Mi4 (R) GABA 4 1.3 0.1% 91.6%
119 SLP249 (R) unclear 4 1.3 0.1% 91.7%
120 Tm3 (R) ACh 4 1.3 0.1% 91.8%
121 Y12 (R) Glu 4 1.3 0.1% 91.9%
122 aMe4 (R) ACh 3 1.0 0.1% 92.0%
123 aMe5 (R) ACh 3 1.0 0.1% 92.1%
124 CL125 (R) unclear 3 1.0 0.1% 92.2%
125 Cm1 (R) ACh 3 1.0 0.1% 92.2%
126 Cm22 (R) GABA 3 1.0 0.1% 92.3%
127 Cm28 (R) unclear 3 1.0 0.1% 92.4%
128 Cm9 (R) Glu 3 1.0 0.1% 92.5%
129 Dm9 (R) Glu 3 1.0 0.1% 92.6%
130 Lat1 (R) unclear 3 1.0 0.1% 92.7%
131 LC10e (R) ACh 3 1.0 0.1% 92.7%
132 LC13 (R) ACh 3 1.0 0.1% 92.8%
133 LoVP6 (R) ACh 3 1.0 0.1% 92.9%
134 LoVP78 (R) ACh 3 1.0 0.1% 93.0%
135 LT58 (R) Glu 3 1.0 0.1% 93.1%
136 MeLo4 (R) ACh 3 1.0 0.1% 93.2%
137 MeTu1 (R) ACh 3 1.0 0.1% 93.2%
138 MeTu3b (R) ACh 3 1.0 0.1% 93.3%
139 MeTu3c (R) ACh 3 1.0 0.1% 93.4%
140 MeVC2 (L) ACh 3 1.0 0.1% 93.5%
141 MeVC21 (R) Glu 3 1.0 0.1% 93.6%
142 MeVP12 (R) ACh 3 1.0 0.1% 93.7%
143 MeVP2 (R) ACh 3 1.0 0.1% 93.7%
144 MeVPMe2 (R) Glu 3 1.0 0.1% 93.8%
145 Mi13 (R) Glu 3 1.0 0.1% 93.9%
146 Mi15 (R) ACh 3 1.0 0.1% 94.0%
147 Mi9 (R) Glu 3 1.0 0.1% 94.1%
148 Pm13 (R) Glu 3 1.0 0.1% 94.2%
149 Pm2b (R) GABA 3 1.0 0.1% 94.2%
150 TmY9a (R) ACh 3 1.0 0.1% 94.3%
151 TmY9b (R) ACh 3 1.0 0.1% 94.4%